Similar effects have been observed in breast cancer cells, where the artificially high arginine levels in DMEM F-12 result in the enzymatic reversal of argininosuccinate lyase (ASL), which canonically catalyzes the conversion of argininosuccinate to arginine and fumarate. Here, ASL is linked to breast carcinoma.